AesculaTech, founded by one of MIT's 35 under 35 Innovators, is dedicated to enhancing lives through smart chemistry. The company designs custom smart materials for biomedical, commercial, and industrial applications. Their core product, AesculaGel, is a platform technology that adapts to various stimuli and can be customized for biocompatibility and material strength. AesculaTech focuses on creating adaptable, high-quality products that challenge conventional norms across medical, industrial, and cosmetic sectors.
Notable figures affiliated with AesculaTech include leading scientists, engineers, and medical experts who share a vision of innovation. The company has garnered attention for its cutting-edge technology and has been featured in prominent technology publications. Key achievements include the development of proprietary materials that respond to environmental changes, positioning AesculaTech as a leader in smart material innovation. Their impact is evident in the advancement of biomedical and industrial applications, driving progress and improving quality of life through intelligent material design.
Quick Facts
How much disclosed funding has AesculaTech raised?
As of Jun 28, 2021, AesculaTech has disclosed funding of $120k (USD).